Global Pre-Exposure Prophylaxis Market Growth 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one's body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
LPI (LP Information)' newest research report, the “Pre-Exposure Prophylaxis Industry Forecast” looks at past sales and reviews total world Pre-Exposure Prophylaxis sales in 2022, providing a comprehensive analysis by region and market sector of projected Pre-Exposure Prophylaxis sales for 2023 through 2029. With Pre-Exposure Prophylaxis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Exposure Prophylaxis industry.
This Insight Report provides a comprehensive analysis of the global Pre-Exposure Prophylaxis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Exposure Prophylaxis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pre-Exposure Prophylaxis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Exposure Prophylaxis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Exposure Prophylaxis.
The global Pre-Exposure Prophylaxis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pre-Exposure Prophylaxis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pre-Exposure Prophylaxis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pre-Exposure Prophylaxis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pre-Exposure Prophylaxis players cover Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science and Lupin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Exposure Prophylaxis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
What is the 10-year outlook for the global Pre-Exposure Prophylaxis market?
What factors are driving Pre-Exposure Prophylaxis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pre-Exposure Prophylaxis market opportunities vary by end market size?
How does Pre-Exposure Prophylaxis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
PrEP, or pre-exposure prophylaxis, is a medicine to prevent HIV. People who are not infected with HIV can take this medicine to decrease the risk of contracting HIV if they get infected with the virus. PrEP is used to stop HIV from spreading throughout one's body. At present, only two daily oral PrEP medications are FDA-approved. Truvada and Descovy are the drugs approved by the FDA for oral usage. Physicians prescribe PrEP to adults and adolescents who are HIV negative and at a higher risk of getting HIV due to sex or injection use.
LPI (LP Information)' newest research report, the “Pre-Exposure Prophylaxis Industry Forecast” looks at past sales and reviews total world Pre-Exposure Prophylaxis sales in 2022, providing a comprehensive analysis by region and market sector of projected Pre-Exposure Prophylaxis sales for 2023 through 2029. With Pre-Exposure Prophylaxis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Pre-Exposure Prophylaxis industry.
This Insight Report provides a comprehensive analysis of the global Pre-Exposure Prophylaxis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Pre-Exposure Prophylaxis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Pre-Exposure Prophylaxis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Pre-Exposure Prophylaxis and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Pre-Exposure Prophylaxis.
The global Pre-Exposure Prophylaxis market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Pre-Exposure Prophylaxis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Pre-Exposure Prophylaxis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Pre-Exposure Prophylaxis is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Pre-Exposure Prophylaxis players cover Gilead Sciences, Teva Pharmaceuticals, Strides Pharma Science and Lupin, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Pre-Exposure Prophylaxis market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
- Truvada
- Discovy
- Adult
- Adolescent
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Gilead Sciences
- Teva Pharmaceuticals
- Strides Pharma Science
- Lupin
What is the 10-year outlook for the global Pre-Exposure Prophylaxis market?
What factors are driving Pre-Exposure Prophylaxis market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Pre-Exposure Prophylaxis market opportunities vary by end market size?
How does Pre-Exposure Prophylaxis break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pre-Exposure Prophylaxis Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pre-Exposure Prophylaxis by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pre-Exposure Prophylaxis by Country/Region, 2018, 2022 & 2029
2.2 Pre-Exposure Prophylaxis Segment by Type
2.2.1 Truvada
2.2.2 Discovy
2.3 Pre-Exposure Prophylaxis Sales by Type
2.3.1 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
2.3.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pre-Exposure Prophylaxis Sale Price by Type (2018-2023)
2.4 Pre-Exposure Prophylaxis Segment by Application
2.4.1 Adult
2.4.2 Adolescent
2.5 Pre-Exposure Prophylaxis Sales by Application
2.5.1 Global Pre-Exposure Prophylaxis Sale Market Share by Application (2018-2023)
2.5.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pre-Exposure Prophylaxis Sale Price by Application (2018-2023)
3 GLOBAL PRE-EXPOSURE PROPHYLAXIS BY COMPANY
3.1 Global Pre-Exposure Prophylaxis Breakdown Data by Company
3.1.1 Global Pre-Exposure Prophylaxis Annual Sales by Company (2018-2023)
3.1.2 Global Pre-Exposure Prophylaxis Sales Market Share by Company (2018-2023)
3.2 Global Pre-Exposure Prophylaxis Annual Revenue by Company (2018-2023)
3.2.1 Global Pre-Exposure Prophylaxis Revenue by Company (2018-2023)
3.2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2018-2023)
3.3 Global Pre-Exposure Prophylaxis Sale Price by Company
3.4 Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pre-Exposure Prophylaxis Product Location Distribution
3.4.2 Players Pre-Exposure Prophylaxis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRE-EXPOSURE PROPHYLAXIS BY GEOGRAPHIC REGION
4.1 World Historic Pre-Exposure Prophylaxis Market Size by Geographic Region (2018-2023)
4.1.1 Global Pre-Exposure Prophylaxis Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pre-Exposure Prophylaxis Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pre-Exposure Prophylaxis Market Size by Country/Region (2018-2023)
4.2.1 Global Pre-Exposure Prophylaxis Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pre-Exposure Prophylaxis Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pre-Exposure Prophylaxis Sales Growth
4.4 APAC Pre-Exposure Prophylaxis Sales Growth
4.5 Europe Pre-Exposure Prophylaxis Sales Growth
4.6 Middle East & Africa Pre-Exposure Prophylaxis Sales Growth
5 AMERICAS
5.1 Americas Pre-Exposure Prophylaxis Sales by Country
5.1.1 Americas Pre-Exposure Prophylaxis Sales by Country (2018-2023)
5.1.2 Americas Pre-Exposure Prophylaxis Revenue by Country (2018-2023)
5.2 Americas Pre-Exposure Prophylaxis Sales by Type
5.3 Americas Pre-Exposure Prophylaxis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pre-Exposure Prophylaxis Sales by Region
6.1.1 APAC Pre-Exposure Prophylaxis Sales by Region (2018-2023)
6.1.2 APAC Pre-Exposure Prophylaxis Revenue by Region (2018-2023)
6.2 APAC Pre-Exposure Prophylaxis Sales by Type
6.3 APAC Pre-Exposure Prophylaxis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pre-Exposure Prophylaxis by Country
7.1.1 Europe Pre-Exposure Prophylaxis Sales by Country (2018-2023)
7.1.2 Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2023)
7.2 Europe Pre-Exposure Prophylaxis Sales by Type
7.3 Europe Pre-Exposure Prophylaxis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pre-Exposure Prophylaxis by Country
8.1.1 Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2018-2023)
8.2 Middle East & Africa Pre-Exposure Prophylaxis Sales by Type
8.3 Middle East & Africa Pre-Exposure Prophylaxis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pre-Exposure Prophylaxis
10.3 Manufacturing Process Analysis of Pre-Exposure Prophylaxis
10.4 Industry Chain Structure of Pre-Exposure Prophylaxis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pre-Exposure Prophylaxis Distributors
11.3 Pre-Exposure Prophylaxis Customer
12 WORLD FORECAST REVIEW FOR PRE-EXPOSURE PROPHYLAXIS BY GEOGRAPHIC REGION
12.1 Global Pre-Exposure Prophylaxis Market Size Forecast by Region
12.1.1 Global Pre-Exposure Prophylaxis Forecast by Region (2024-2029)
12.1.2 Global Pre-Exposure Prophylaxis Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pre-Exposure Prophylaxis Forecast by Type
12.7 Global Pre-Exposure Prophylaxis Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Strides Pharma Science
13.3.1 Strides Pharma Science Company Information
13.3.2 Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Strides Pharma Science Main Business Overview
13.3.5 Strides Pharma Science Latest Developments
13.4 Lupin
13.4.1 Lupin Company Information
13.4.2 Lupin Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lupin Main Business Overview
13.4.5 Lupin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Pre-Exposure Prophylaxis Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Pre-Exposure Prophylaxis by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Pre-Exposure Prophylaxis by Country/Region, 2018, 2022 & 2029
2.2 Pre-Exposure Prophylaxis Segment by Type
2.2.1 Truvada
2.2.2 Discovy
2.3 Pre-Exposure Prophylaxis Sales by Type
2.3.1 Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
2.3.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Type (2018-2023)
2.3.3 Global Pre-Exposure Prophylaxis Sale Price by Type (2018-2023)
2.4 Pre-Exposure Prophylaxis Segment by Application
2.4.1 Adult
2.4.2 Adolescent
2.5 Pre-Exposure Prophylaxis Sales by Application
2.5.1 Global Pre-Exposure Prophylaxis Sale Market Share by Application (2018-2023)
2.5.2 Global Pre-Exposure Prophylaxis Revenue and Market Share by Application (2018-2023)
2.5.3 Global Pre-Exposure Prophylaxis Sale Price by Application (2018-2023)
3 GLOBAL PRE-EXPOSURE PROPHYLAXIS BY COMPANY
3.1 Global Pre-Exposure Prophylaxis Breakdown Data by Company
3.1.1 Global Pre-Exposure Prophylaxis Annual Sales by Company (2018-2023)
3.1.2 Global Pre-Exposure Prophylaxis Sales Market Share by Company (2018-2023)
3.2 Global Pre-Exposure Prophylaxis Annual Revenue by Company (2018-2023)
3.2.1 Global Pre-Exposure Prophylaxis Revenue by Company (2018-2023)
3.2.2 Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2018-2023)
3.3 Global Pre-Exposure Prophylaxis Sale Price by Company
3.4 Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Pre-Exposure Prophylaxis Product Location Distribution
3.4.2 Players Pre-Exposure Prophylaxis Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 WORLD HISTORIC REVIEW FOR PRE-EXPOSURE PROPHYLAXIS BY GEOGRAPHIC REGION
4.1 World Historic Pre-Exposure Prophylaxis Market Size by Geographic Region (2018-2023)
4.1.1 Global Pre-Exposure Prophylaxis Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Pre-Exposure Prophylaxis Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Pre-Exposure Prophylaxis Market Size by Country/Region (2018-2023)
4.2.1 Global Pre-Exposure Prophylaxis Annual Sales by Country/Region (2018-2023)
4.2.2 Global Pre-Exposure Prophylaxis Annual Revenue by Country/Region (2018-2023)
4.3 Americas Pre-Exposure Prophylaxis Sales Growth
4.4 APAC Pre-Exposure Prophylaxis Sales Growth
4.5 Europe Pre-Exposure Prophylaxis Sales Growth
4.6 Middle East & Africa Pre-Exposure Prophylaxis Sales Growth
5 AMERICAS
5.1 Americas Pre-Exposure Prophylaxis Sales by Country
5.1.1 Americas Pre-Exposure Prophylaxis Sales by Country (2018-2023)
5.1.2 Americas Pre-Exposure Prophylaxis Revenue by Country (2018-2023)
5.2 Americas Pre-Exposure Prophylaxis Sales by Type
5.3 Americas Pre-Exposure Prophylaxis Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Pre-Exposure Prophylaxis Sales by Region
6.1.1 APAC Pre-Exposure Prophylaxis Sales by Region (2018-2023)
6.1.2 APAC Pre-Exposure Prophylaxis Revenue by Region (2018-2023)
6.2 APAC Pre-Exposure Prophylaxis Sales by Type
6.3 APAC Pre-Exposure Prophylaxis Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Pre-Exposure Prophylaxis by Country
7.1.1 Europe Pre-Exposure Prophylaxis Sales by Country (2018-2023)
7.1.2 Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2023)
7.2 Europe Pre-Exposure Prophylaxis Sales by Type
7.3 Europe Pre-Exposure Prophylaxis Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Pre-Exposure Prophylaxis by Country
8.1.1 Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2018-2023)
8.1.2 Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2018-2023)
8.2 Middle East & Africa Pre-Exposure Prophylaxis Sales by Type
8.3 Middle East & Africa Pre-Exposure Prophylaxis Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Pre-Exposure Prophylaxis
10.3 Manufacturing Process Analysis of Pre-Exposure Prophylaxis
10.4 Industry Chain Structure of Pre-Exposure Prophylaxis
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Pre-Exposure Prophylaxis Distributors
11.3 Pre-Exposure Prophylaxis Customer
12 WORLD FORECAST REVIEW FOR PRE-EXPOSURE PROPHYLAXIS BY GEOGRAPHIC REGION
12.1 Global Pre-Exposure Prophylaxis Market Size Forecast by Region
12.1.1 Global Pre-Exposure Prophylaxis Forecast by Region (2024-2029)
12.1.2 Global Pre-Exposure Prophylaxis Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Pre-Exposure Prophylaxis Forecast by Type
12.7 Global Pre-Exposure Prophylaxis Forecast by Application
13 KEY PLAYERS ANALYSIS
13.1 Gilead Sciences
13.1.1 Gilead Sciences Company Information
13.1.2 Gilead Sciences Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.1.3 Gilead Sciences Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Gilead Sciences Main Business Overview
13.1.5 Gilead Sciences Latest Developments
13.2 Teva Pharmaceuticals
13.2.1 Teva Pharmaceuticals Company Information
13.2.2 Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.2.3 Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Teva Pharmaceuticals Main Business Overview
13.2.5 Teva Pharmaceuticals Latest Developments
13.3 Strides Pharma Science
13.3.1 Strides Pharma Science Company Information
13.3.2 Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.3.3 Strides Pharma Science Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Strides Pharma Science Main Business Overview
13.3.5 Strides Pharma Science Latest Developments
13.4 Lupin
13.4.1 Lupin Company Information
13.4.2 Lupin Pre-Exposure Prophylaxis Product Portfolios and Specifications
13.4.3 Lupin Pre-Exposure Prophylaxis Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Lupin Main Business Overview
13.4.5 Lupin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Pre-Exposure Prophylaxis Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pre-Exposure Prophylaxis Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Truvada
Table 4. Major Players of Discovy
Table 5. Global Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 6. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Table 7. Global Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2023)
Table 9. Global Pre-Exposure Prophylaxis Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 11. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Table 12. Global Pre-Exposure Prophylaxis Revenue by Application (2018-2023)
Table 13. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2023)
Table 14. Global Pre-Exposure Prophylaxis Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pre-Exposure Prophylaxis Sales by Company (2018-2023) & (K Units)
Table 16. Global Pre-Exposure Prophylaxis Sales Market Share by Company (2018-2023)
Table 17. Global Pre-Exposure Prophylaxis Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2018-2023)
Table 19. Global Pre-Exposure Prophylaxis Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution and Sales Area
Table 21. Players Pre-Exposure Prophylaxis Products Offered
Table 22. Pre-Exposure Prophylaxis Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pre-Exposure Prophylaxis Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Pre-Exposure Prophylaxis Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pre-Exposure Prophylaxis Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pre-Exposure Prophylaxis Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pre-Exposure Prophylaxis Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Pre-Exposure Prophylaxis Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pre-Exposure Prophylaxis Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pre-Exposure Prophylaxis Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 34. Americas Pre-Exposure Prophylaxis Sales Market Share by Country (2018-2023)
Table 35. Americas Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country (2018-2023)
Table 37. Americas Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 38. Americas Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 39. APAC Pre-Exposure Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 40. APAC Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2023)
Table 41. APAC Pre-Exposure Prophylaxis Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2023)
Table 43. APAC Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 44. APAC Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 45. Europe Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 46. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2018-2023)
Table 47. Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2018-2023)
Table 49. Europe Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 50. Europe Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Pre-Exposure Prophylaxis
Table 58. Key Market Challenges & Risks of Pre-Exposure Prophylaxis
Table 59. Key Industry Trends of Pre-Exposure Prophylaxis
Table 60. Pre-Exposure Prophylaxis Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pre-Exposure Prophylaxis Distributors List
Table 63. Pre-Exposure Prophylaxis Customer List
Table 64. Global Pre-Exposure Prophylaxis Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Pre-Exposure Prophylaxis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pre-Exposure Prophylaxis Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Pre-Exposure Prophylaxis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pre-Exposure Prophylaxis Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Pre-Exposure Prophylaxis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pre-Exposure Prophylaxis Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Pre-Exposure Prophylaxis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pre-Exposure Prophylaxis Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Pre-Exposure Prophylaxis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pre-Exposure Prophylaxis Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Pre-Exposure Prophylaxis Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pre-Exposure Prophylaxis Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Pre-Exposure Prophylaxis Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Gilead Sciences Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 79. Gilead Sciences Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 80. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Gilead Sciences Main Business
Table 82. Gilead Sciences Latest Developments
Table 83. Teva Pharmaceuticals Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 85. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Teva Pharmaceuticals Main Business
Table 87. Teva Pharmaceuticals Latest Developments
Table 88. Strides Pharma Science Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 89. Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 90. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Strides Pharma Science Main Business
Table 92. Strides Pharma Science Latest Developments
Table 93. Lupin Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 94. Lupin Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 95. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Lupin Main Business
Table 97. Lupin Latest Developments
Table 1. Pre-Exposure Prophylaxis Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Pre-Exposure Prophylaxis Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Truvada
Table 4. Major Players of Discovy
Table 5. Global Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 6. Global Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Table 7. Global Pre-Exposure Prophylaxis Revenue by Type (2018-2023) & ($ million)
Table 8. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2023)
Table 9. Global Pre-Exposure Prophylaxis Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 11. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Table 12. Global Pre-Exposure Prophylaxis Revenue by Application (2018-2023)
Table 13. Global Pre-Exposure Prophylaxis Revenue Market Share by Application (2018-2023)
Table 14. Global Pre-Exposure Prophylaxis Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Pre-Exposure Prophylaxis Sales by Company (2018-2023) & (K Units)
Table 16. Global Pre-Exposure Prophylaxis Sales Market Share by Company (2018-2023)
Table 17. Global Pre-Exposure Prophylaxis Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Company (2018-2023)
Table 19. Global Pre-Exposure Prophylaxis Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Pre-Exposure Prophylaxis Producing Area Distribution and Sales Area
Table 21. Players Pre-Exposure Prophylaxis Products Offered
Table 22. Pre-Exposure Prophylaxis Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Pre-Exposure Prophylaxis Sales by Geographic Region (2018-2023) & (K Units)
Table 26. Global Pre-Exposure Prophylaxis Sales Market Share Geographic Region (2018-2023)
Table 27. Global Pre-Exposure Prophylaxis Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Pre-Exposure Prophylaxis Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Pre-Exposure Prophylaxis Sales by Country/Region (2018-2023) & (K Units)
Table 30. Global Pre-Exposure Prophylaxis Sales Market Share by Country/Region (2018-2023)
Table 31. Global Pre-Exposure Prophylaxis Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Pre-Exposure Prophylaxis Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 34. Americas Pre-Exposure Prophylaxis Sales Market Share by Country (2018-2023)
Table 35. Americas Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country (2018-2023)
Table 37. Americas Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 38. Americas Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 39. APAC Pre-Exposure Prophylaxis Sales by Region (2018-2023) & (K Units)
Table 40. APAC Pre-Exposure Prophylaxis Sales Market Share by Region (2018-2023)
Table 41. APAC Pre-Exposure Prophylaxis Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Pre-Exposure Prophylaxis Revenue Market Share by Region (2018-2023)
Table 43. APAC Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 44. APAC Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 45. Europe Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 46. Europe Pre-Exposure Prophylaxis Sales Market Share by Country (2018-2023)
Table 47. Europe Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country (2018-2023)
Table 49. Europe Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 50. Europe Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 51. Middle East & Africa Pre-Exposure Prophylaxis Sales by Country (2018-2023) & (K Units)
Table 52. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Pre-Exposure Prophylaxis Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Pre-Exposure Prophylaxis Sales by Type (2018-2023) & (K Units)
Table 56. Middle East & Africa Pre-Exposure Prophylaxis Sales by Application (2018-2023) & (K Units)
Table 57. Key Market Drivers & Growth Opportunities of Pre-Exposure Prophylaxis
Table 58. Key Market Challenges & Risks of Pre-Exposure Prophylaxis
Table 59. Key Industry Trends of Pre-Exposure Prophylaxis
Table 60. Pre-Exposure Prophylaxis Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Pre-Exposure Prophylaxis Distributors List
Table 63. Pre-Exposure Prophylaxis Customer List
Table 64. Global Pre-Exposure Prophylaxis Sales Forecast by Region (2024-2029) & (K Units)
Table 65. Global Pre-Exposure Prophylaxis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Pre-Exposure Prophylaxis Sales Forecast by Country (2024-2029) & (K Units)
Table 67. Americas Pre-Exposure Prophylaxis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Pre-Exposure Prophylaxis Sales Forecast by Region (2024-2029) & (K Units)
Table 69. APAC Pre-Exposure Prophylaxis Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Pre-Exposure Prophylaxis Sales Forecast by Country (2024-2029) & (K Units)
Table 71. Europe Pre-Exposure Prophylaxis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Pre-Exposure Prophylaxis Sales Forecast by Country (2024-2029) & (K Units)
Table 73. Middle East & Africa Pre-Exposure Prophylaxis Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Pre-Exposure Prophylaxis Sales Forecast by Type (2024-2029) & (K Units)
Table 75. Global Pre-Exposure Prophylaxis Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Pre-Exposure Prophylaxis Sales Forecast by Application (2024-2029) & (K Units)
Table 77. Global Pre-Exposure Prophylaxis Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Gilead Sciences Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 79. Gilead Sciences Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 80. Gilead Sciences Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Gilead Sciences Main Business
Table 82. Gilead Sciences Latest Developments
Table 83. Teva Pharmaceuticals Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 84. Teva Pharmaceuticals Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 85. Teva Pharmaceuticals Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Teva Pharmaceuticals Main Business
Table 87. Teva Pharmaceuticals Latest Developments
Table 88. Strides Pharma Science Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 89. Strides Pharma Science Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 90. Strides Pharma Science Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Strides Pharma Science Main Business
Table 92. Strides Pharma Science Latest Developments
Table 93. Lupin Basic Information, Pre-Exposure Prophylaxis Manufacturing Base, Sales Area and Its Competitors
Table 94. Lupin Pre-Exposure Prophylaxis Product Portfolios and Specifications
Table 95. Lupin Pre-Exposure Prophylaxis Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Lupin Main Business
Table 97. Lupin Latest Developments
LIST OF FIGURES
Figure 1. Picture of Pre-Exposure Prophylaxis
Figure 2. Pre-Exposure Prophylaxis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pre-Exposure Prophylaxis Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pre-Exposure Prophylaxis Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pre-Exposure Prophylaxis Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Truvada
Figure 10. Product Picture of Discovy
Figure 11. Global Pre-Exposure Prophylaxis Sales Market Share by Type in 2022
Figure 12. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2023)
Figure 13. Pre-Exposure Prophylaxis Consumed in Adult
Figure 14. Global Pre-Exposure Prophylaxis Market: Adult (2018-2023) & (K Units)
Figure 15. Pre-Exposure Prophylaxis Consumed in Adolescent
Figure 16. Global Pre-Exposure Prophylaxis Market: Adolescent (2018-2023) & (K Units)
Figure 17. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2022)
Figure 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Application in 2022
Figure 19. Pre-Exposure Prophylaxis Sales Market by Company in 2022 (K Units)
Figure 20. Global Pre-Exposure Prophylaxis Sales Market Share by Company in 2022
Figure 21. Pre-Exposure Prophylaxis Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Company in 2022
Figure 23. Global Pre-Exposure Prophylaxis Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pre-Exposure Prophylaxis Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 26. Americas Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 28. APAC Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 30. Europe Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pre-Exposure Prophylaxis Sales Market Share by Country in 2022
Figure 34. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country in 2022
Figure 35. Americas Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 36. Americas Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 37. United States Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pre-Exposure Prophylaxis Sales Market Share by Region in 2022
Figure 42. APAC Pre-Exposure Prophylaxis Revenue Market Share by Regions in 2022
Figure 43. APAC Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 44. APAC Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 45. China Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pre-Exposure Prophylaxis Sales Market Share by Country in 2022
Figure 53. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country in 2022
Figure 54. Europe Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 55. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 56. Germany Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pre-Exposure Prophylaxis in 2022
Figure 71. Manufacturing Process Analysis of Pre-Exposure Prophylaxis
Figure 72. Industry Chain Structure of Pre-Exposure Prophylaxis
Figure 73. Channels of Distribution
Figure 74. Global Pre-Exposure Prophylaxis Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Application (2024-2029)
Figure 1. Picture of Pre-Exposure Prophylaxis
Figure 2. Pre-Exposure Prophylaxis Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Pre-Exposure Prophylaxis Sales Growth Rate 2018-2029 (K Units)
Figure 7. Global Pre-Exposure Prophylaxis Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Pre-Exposure Prophylaxis Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Truvada
Figure 10. Product Picture of Discovy
Figure 11. Global Pre-Exposure Prophylaxis Sales Market Share by Type in 2022
Figure 12. Global Pre-Exposure Prophylaxis Revenue Market Share by Type (2018-2023)
Figure 13. Pre-Exposure Prophylaxis Consumed in Adult
Figure 14. Global Pre-Exposure Prophylaxis Market: Adult (2018-2023) & (K Units)
Figure 15. Pre-Exposure Prophylaxis Consumed in Adolescent
Figure 16. Global Pre-Exposure Prophylaxis Market: Adolescent (2018-2023) & (K Units)
Figure 17. Global Pre-Exposure Prophylaxis Sales Market Share by Application (2022)
Figure 18. Global Pre-Exposure Prophylaxis Revenue Market Share by Application in 2022
Figure 19. Pre-Exposure Prophylaxis Sales Market by Company in 2022 (K Units)
Figure 20. Global Pre-Exposure Prophylaxis Sales Market Share by Company in 2022
Figure 21. Pre-Exposure Prophylaxis Revenue Market by Company in 2022 ($ Million)
Figure 22. Global Pre-Exposure Prophylaxis Revenue Market Share by Company in 2022
Figure 23. Global Pre-Exposure Prophylaxis Sales Market Share by Geographic Region (2018-2023)
Figure 24. Global Pre-Exposure Prophylaxis Revenue Market Share by Geographic Region in 2022
Figure 25. Americas Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 26. Americas Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 27. APAC Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 28. APAC Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 29. Europe Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 30. Europe Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 31. Middle East & Africa Pre-Exposure Prophylaxis Sales 2018-2023 (K Units)
Figure 32. Middle East & Africa Pre-Exposure Prophylaxis Revenue 2018-2023 ($ Millions)
Figure 33. Americas Pre-Exposure Prophylaxis Sales Market Share by Country in 2022
Figure 34. Americas Pre-Exposure Prophylaxis Revenue Market Share by Country in 2022
Figure 35. Americas Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 36. Americas Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 37. United States Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 38. Canada Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 39. Mexico Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 40. Brazil Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 41. APAC Pre-Exposure Prophylaxis Sales Market Share by Region in 2022
Figure 42. APAC Pre-Exposure Prophylaxis Revenue Market Share by Regions in 2022
Figure 43. APAC Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 44. APAC Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 45. China Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 46. Japan Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 47. South Korea Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 48. Southeast Asia Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 49. India Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 50. Australia Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 51. China Taiwan Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 52. Europe Pre-Exposure Prophylaxis Sales Market Share by Country in 2022
Figure 53. Europe Pre-Exposure Prophylaxis Revenue Market Share by Country in 2022
Figure 54. Europe Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 55. Europe Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 56. Germany Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 57. France Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 58. UK Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 59. Italy Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 60. Russia Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 61. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Country in 2022
Figure 62. Middle East & Africa Pre-Exposure Prophylaxis Revenue Market Share by Country in 2022
Figure 63. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Type (2018-2023)
Figure 64. Middle East & Africa Pre-Exposure Prophylaxis Sales Market Share by Application (2018-2023)
Figure 65. Egypt Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 66. South Africa Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 67. Israel Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 68. Turkey Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 69. GCC Country Pre-Exposure Prophylaxis Revenue Growth 2018-2023 ($ Millions)
Figure 70. Manufacturing Cost Structure Analysis of Pre-Exposure Prophylaxis in 2022
Figure 71. Manufacturing Process Analysis of Pre-Exposure Prophylaxis
Figure 72. Industry Chain Structure of Pre-Exposure Prophylaxis
Figure 73. Channels of Distribution
Figure 74. Global Pre-Exposure Prophylaxis Sales Market Forecast by Region (2024-2029)
Figure 75. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Region (2024-2029)
Figure 76. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Type (2024-2029)
Figure 77. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Type (2024-2029)
Figure 78. Global Pre-Exposure Prophylaxis Sales Market Share Forecast by Application (2024-2029)
Figure 79. Global Pre-Exposure Prophylaxis Revenue Market Share Forecast by Application (2024-2029)
